Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
| Next EPS Date | 7/30/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +18.9% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +9.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | $0.56 | N/A | N/A | $3.87B | = | N/A | N/A | ||
| 1/28/26 | Q425 | $0.96 | $0.65 | +$0.31 | $4.71B | $4.33B | = |  | | Details | |
| 11/5/25 | Q325 | $0.78 | $0.68 | +$0.10 | $4.48B | $4.36B | = | | | Details | |
| 7/30/25 | Q225 | $0.66 | $0.63 | +$0.03 | $4.2B | $4.28B | = | | | Details | |
| 5/7/25 | Q125 | $0.52 | $0.48 | +$0.04 | $3.9B | $3.98B | = | | | Details | |
| 1/29/25 | Q424 | $0.71 | $0.69 | +$0.02 | $4.23B | $4.1B | = | | | Details | |
| 11/6/24 | Q324 | $0.69 | $0.66 | +$0.03 | $4.3B | $4.14B | = | | | Details | |
| 7/31/24 | Q224 | $0.61 | $0.55 | +$0.06 | $4.2B | $4.06B | = | | | Details |
